Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ORKA	ORUKA THERAPEUTICS INC	$1.47B	-25.80%	-24.80%	-20.81%	-31.60%	0.05	16.94	N/A	N/A	N/A
SPRB	SPRUCE BIOSCIENCES INC	$93.24M	-305.40%	-168.00%	-762.62%	955.90%	1.84	1.54	100.00%	-6,869.30%	-6,440.17%
CRDF	CARDIFF ONCOLOGY INC	$189.28M	-77.20%	-62.80%	-102.75%	-117.30%	0.31	4.20	100.00%	-10,069.10%	-10,064.27%
MGRX	MANGOCEUTICALS INC	$10.29M	-116.30%	-108.00%	-128.36%	2,022.00%	0.05	0.74	60.60%	-4,308.30%	-4,323.88%
ATON	ALPHATON CAPITAL CORP	$992.17k	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$14.07M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$285.59M	78.40%	48.00%	41.45%	86.10%	0.35	9.74	-22.00%	20,587.50%	21,650.75%
DRIO	DARIOHEALTH CORP	$77.02M	-89.60%	-55.40%	-37.79%	-135.80%	0.57	4.55	56.90%	-257.70%	-165.70%
RYTM	RHYTHM PHARMACEUTICALS INC	$7.14B	-445.30%	-47.70%	-42.34%	-84.70%	1.42	4.75	89.40%	-113.40%	-97.79%
RBOT	VICARIOUS SURGICAL INC	$14.21M	-181.80%	-111.10%	-204.78%	-107.50%	1.08	4.75	N/A	N/A	N/A
IMNN	IMUNON INC	$11.70M	-501.10%	-166.80%	-299.16%	239,282.00%	1.20	1.73	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$5.16B	-39.10%	-36.90%	-42.80%	-46.30%	0.07	15.86	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$204.43M	-39.10%	-33.20%	-39.26%	-49.80%	0.22	8.66	100.00%	-9,841.90%	-10,014.70%
VTGN	VISTAGEN THERAPEUTICS INC	$26.07M	-90.70%	-76.20%	-92.50%	-747.70%	0.22	5.79	100.00%	-8,631.90%	-8,631.90%
ACET	ADICET BIO INC	$80.65M	-77.90%	-64.30%	-94.62%	-84.00%	0.29	5.62	N/A	N/A	N/A
MOH	MOLINA HEALTHCARE INC	$8.92B	20.10%	5.50%	16.10%	26.30%	2.75	1.68	10.10%	2.00%	2.97%
IMRX	IMMUNEERING CORP	$424.87M	-73.50%	-65.00%	-26.99%	-1,472.40%	0.06	24.00	N/A	N/A	N/A
PHIO	PHIO PHARMACEUTICALS CORP	$11.30M	-86.40%	-75.80%	-80.83%	960.20%	0.17	6.90	N/A	N/A	N/A
EVH	EVOLENT HEALTH INC	$446.40M	-19.70%	-7.20%	-5.62%	-13.50%	1.91	1.33	18.40%	-8.80%	-5.54%
AVTX	AVALO THERAPEUTICS INC	$329.31M	-88.40%	-73.90%	-86.18%	-288.20%	0.37	14.28	54.70%	-52,019.80%	-52,575.52%
AMIX	AUTONOMIX MEDICAL INC	$3.79M	-213.40%	-172.60%	-257.56%	1,440.30%	0.23	5.31	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$3.24B	-50.90%	-42.70%	-51.39%	-43.50%	0.30	12.21	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$243.42k	-173.80%	-70.50%	-364.89%	138.60%	2.73	1.32	N/A	N/A	N/A
INO	INOVIO PHARMACEUTICALS INC	$93.21M	-307.60%	-127.90%	24,665.13%	-846.50%	-9.99	0.79	100.00%	-59,281.70%	-59,281.69%
OSCR	OSCAR HEALTH INC	$3.80B	-21.60%	-4.30%	-12.09%	151.20%	4.61	0.95	16.20%	-2.20%	-1.89%
DNTH	DIANTHUS THERAPEUTICS INC	$1.77B	-33.00%	-31.10%	-22.82%	-34.90%	0.06	17.35	100.00%	-4,104.80%	-4,104.78%
BTAI	BIOXCEL THERAPEUTICS INC	$34.99M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
VSTM	VERASTEM INC	$515.51M	N/A	-159.10%	-204.07%	-526.30%	-12.39	2.58	82.00%	-1,802.10%	-1,786.77%
NNOX	NANO-X IMAGING LTD	$183.12M	-32.50%	-29.00%	-35.30%	-75.50%	0.12	4.14	-98.00%	-452.80%	-469.77%
DTIL	PRECISION BIOSCIENCES INC	$55.15M	-213.80%	-72.20%	-104.61%	-207.20%	4.62	3.45	100.00%	-11,977.40%	-11,767.34%
RVMD	REVOLUTION MEDICINES INC	$15.40B	-49.20%	-40.00%	-47.32%	-46.80%	0.41	8.05	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$301.50M	-3,645.20%	-133.00%	-127.83%	-149.70%	-36.96	4.27	100.00%	-4,073,233.30%	-4,073,233.33%
DNLI	DENALI THERAPEUTICS INC	$2.42B	-46.30%	-41.00%	-51.65%	-47.40%	0.14	9.79	N/A	N/A	N/A
OSRH	OSR HOLDINGS INC	$14.48M	N/A	N/A	N/A	N/A	0.53	0.21	N/A	N/A	N/A
VIR	VIR BIOTECHNOLOGY INC	$838.92M	-50.80%	-40.60%	-52.89%	-55.50%	0.28	7.25	95.90%	-2,963.50%	-2,961.95%
IMUX	IMMUNIC INC	$64.23M	-716.20%	-252.10%	-969.85%	507.30%	2.88	1.31	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$420.96M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
ALEC	ALECTOR INC	$170.28M	-123.00%	-27.50%	-42.18%	-38.10%	4.81	3.76	100.00%	-156.00%	-155.96%
IFRX	INFLARX NV	$68.42M	-68.50%	-53.20%	-86.90%	-104.20%	0.44	3.33	-8,223.10%	-63,818.90%	-63,757.59%
GTBP	GT BIOPHARMA INC	$8.35M	-1,161.90%	-203.50%	-303.27%	392.30%	0.44	3.27	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.08B	-55.20%	-43.10%	-51.12%	-96.30%	0.29	3.41	24.00%	-158.80%	-159.06%
RMTI	ROCKWELL MEDICAL INC	$32.86M	-16.80%	-9.90%	-9.16%	-13.10%	0.55	3.92	15.10%	-7.30%	-5.81%
CVRX	CVRX INC	$186.09M	-84.50%	-42.10%	-46.13%	-69.50%	1.32	9.62	84.50%	-92.90%	-82.50%
ELAB	PMGC HOLDINGS INC	$1.10M	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
RZLT	REZOLUTE INC	$218.84M	-62.80%	-57.10%	-51.99%	-81.70%	0.08	15.15	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$186.53M	-370.50%	-50.80%	-67.86%	-133.70%	102.78	1.12	N/A	N/A	N/A
XAIR	BEYOND AIR INC	$5.81M	-272.40%	-119.10%	-129.34%	-123.30%	1.40	4.24	-6.70%	-632.50%	-592.57%
AVIR	ATEA PHARMACEUTICALS INC	$278.91M	-38.40%	-35.90%	-45.29%	-48.10%	0.09	16.66	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$272.74M	-26.40%	-25.60%	-28.62%	-33.40%	0.03	18.38	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$3.00B	-31.60%	-29.00%	-29.38%	-36.40%	0.10	23.45	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.20B	-389.90%	-153.40%	-263.08%	-206.40%	-24.84	2.86	N/A	N/A	N/A
BIAF	BIOAFFINITY TECHNOLOGIES INC	$5.31M	-545.50%	-207.90%	-159.38%	-2,419.70%	0.30	3.65	27.90%	-217.50%	-216.06%
STSS	SHARPS TECHNOLOGY INC	$57.30M	-90.80%	-85.70%	-23.60%	-94.60%	0.03	3.74	-718.70%	-34,070.10%	-33,385.77%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.55B	-198.60%	-60.60%	-58.75%	-180.50%	0.50	5.47	46.40%	-186.90%	-166.90%
ELDN	ELEDON PHARMACEUTICALS INC	$90.50M	-94.90%	-49.30%	-65.03%	-56.80%	1.10	6.74	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$3.46B	-46.20%	-43.40%	-54.38%	-55.80%	0.09	12.53	100.00%	-4,084.50%	-4,129.39%
RCKT	ROCKET PHARMACEUTICALS INC	$379.86M	-62.40%	-53.90%	-70.95%	-83.00%	0.17	7.30	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$7.77B	N/A	-56.50%	-54.98%	-36.10%	-3.76	6.88	100.00%	-862.20%	-816.07%
LFMD	LIFEMD INC	$164.14M	N/A	-10.80%	-22.51%	11.70%	47.64	0.73	87.00%	-3.10%	-0.83%
STEX	STREAMEX CORP	$119.81M	N/A	-65.00%	-826.64%	68.50%	-19.74	0.12	100.00%	-306,861.50%	-312,469.23%
VANI	VIVANI MEDICAL INC	$89.73M	-293.60%	-79.50%	-142.87%	-80.80%	18.13	0.61	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$105.30M	-50.00%	-44.00%	-57.49%	-52.80%	0.15	11.65	N/A	N/A	N/A
GNPX	GENPREX INC	$3.97M	-891.70%	-389.10%	-1,658.99%	-18,136.00%	3.64	0.67	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$87.67M	-310.10%	-145.40%	-241.56%	-1,835.00%	2.53	3.18	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$921.98M	-27.20%	-26.00%	-30.02%	-205.00%	0.05	14.14	N/A	N/A	N/A
TIL	INSTIL BIO INC	$74.60M	-53.00%	-31.80%	-32.91%	-22.50%	0.76	34.45	N/A	N/A	N/A
LAB	STANDARD BIOTOOLS INC	$492.24M	-29.30%	-22.40%	-29.33%	-42.40%	0.35	4.38	47.90%	-99.60%	-98.29%
PRQR	PROQR THERAPEUTICS NV	$217.58M	-58.40%	-29.30%	-44.87%	-9,969.30%	1.18	3.36	100.00%	-264.80%	-254.60%
AGIO	AGIOS PHARMACEUTICALS INC	$1.59B	-28.40%	-26.40%	-31.29%	-28.90%	0.08	13.82	87.20%	-895.90%	-915.68%
QNRX	QUOIN PHARMACEUTICALS LTD	$21.19M	-334.40%	-125.20%	-2,088.80%	-453.90%	-6.29	1.04	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$4.46B	-84.90%	-76.10%	-88.98%	8,805.10%	0.12	9.07	N/A	N/A	N/A
TRAW	TRAWS PHARMA INC	$9.03M	-2,912.00%	518.00%	2,048.95%	-1,528.40%	1.74	1.22	100.00%	3,280.00%	3,280.04%
COCH	ENVOY MEDICAL INC	$19.03M	N/A	-286.10%	2,455.27%	-128.40%	-2.05	0.64	-294.20%	-13,755.30%	-9,525.96%
SLDB	SOLID BIOSCIENCES INC	$439.41M	-73.60%	-60.00%	-70.12%	-112.70%	0.26	6.74	N/A	N/A	N/A
LUCD	LUCID DIAGNOSTICS INC	$150.07M	-781.30%	-169.50%	-197.32%	-1,081.40%	1.06	1.90	-58.10%	-1,496.80%	-1,210.75%
SNGX	SOLIGENIX INC	$13.52M	-267.10%	-135.70%	-149.12%	441.10%	0.49	3.18	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$4.49B	-122.00%	-86.50%	-100.33%	-144.60%	0.68	6.31	N/A	N/A	N/A
VKTX	VIKING THERAPEUTICS INC	$3.98B	-29.30%	-28.40%	-33.28%	-31.20%	0.04	28.34	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$299.09M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
EYPT	EYEPOINT PHARMACEUTICALS INC	$1.51B	-76.10%	-61.70%	-92.76%	-87.80%	0.26	7.18	94.10%	-486.00%	-485.49%
NRIX	NURIX THERAPEUTICS INC	$1.46B	-53.60%	-40.80%	-55.44%	-52.30%	0.40	5.35	100.00%	-292.50%	-291.58%
KALA	KALA BIO INC	$4.56M	-2,323.90%	-87.00%	414.59%	-230.60%	-3.89	0.75	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$66.51M	-55.30%	-51.00%	-69.86%	-78.60%	0.11	10.77	N/A	N/A	N/A
ENLV	ENLIVEX THERAPEUTICS LTD	$17.08M	-62.90%	-53.30%	-82.65%	-29,748.70%	0.20	6.43	N/A	N/A	N/A
DCGO	DOCGO INC	$85.88M	-17.20%	-12.50%	-25.25%	-36.70%	0.34	2.59	31.20%	-14.00%	-19.22%
ABSI	ABSCI CORP	$524.80M	-60.20%	-50.90%	-52.98%	-103.30%	0.17	5.89	100.00%	-4,071.20%	-4,051.97%
AVBP	ARRIVENT BIOPHARMA INC	$830.58M	-59.70%	-55.70%	-49.64%	-90.90%	0.07	14.90	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$854.46M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
CDT	CDT EQUITY INC	$2.09M	-2,194.50%	-289.50%	-444.72%	-897.30%	1.00	1.66	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$185.11M	-64.40%	-38.70%	-51.82%	-44.80%	0.72	5.76	100.00%	-395.50%	-395.08%
NVCT	NUVECTIS PHARMA INC	$193.39M	-155.40%	-99.90%	-115.81%	284.60%	0.48	3.07	N/A	N/A	N/A
NXL	NEXALIN TECHNOLOGY INC	$10.41M	-207.50%	-184.50%	-182.05%	-259.70%	0.08	13.47	69.50%	-5,530.40%	-5,531.56%
REPL	REPLIMUNE GROUP INC	$762.47M	-82.80%	-61.60%	-89.68%	-75.20%	0.48	6.31	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$626.37M	-163.50%	-61.20%	-56.38%	-72.20%	1.38	6.61	100.00%	-3,301.60%	-3,301.64%
WHWK	WHITEHAWK THERAPEUTICS INC	$114.05M	-10.40%	-9.60%	-9.94%	-37.60%	0.06	16.76	89.20%	-108.60%	-108.58%
SNTI	SENTI BIOSCIENCES INC	$27.34M	-197.70%	-63.10%	-117.03%	-75.10%	5.49	1.51	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$16.51M	N/A	N/A	N/A	N/A	-1.82	0.42	N/A	N/A	N/A
PCVX	VAXCYTE INC	$6.04B	-21.10%	-19.70%	-22.12%	-22.30%	0.10	8.83	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$13.02B	-311.20%	-262.40%	-463.89%	-997.70%	0.36	3.80	N/A	N/A	N/A
ELUT	ELUTIA INC	$29.59M	N/A	-76.40%	197.10%	-150.20%	-1.67	0.45	46.00%	-125.60%	-111.50%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	615	+0.27%	-2.56%	+0.97%	-41.73%	146.65x	5.25x	-24.86%	-9.63%	-5.94%	+53.28%	Strong Buy
Diagnostics & Research	57	-0.98%	-1.53%	-3.92%	+15.95%	22.62x	4.43x	-1.14%	+6.19%	+13.13%	+8.73%	Buy
Drug Manufacturers - General	20	-0.36%	-0.64%	+0.75%	+29.59%	46.13x	6.93x	+106.72%	+12.28%	+20.38%	+4.48%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.56%	-2.69%	+2.08%	-2.13%	-31.58x	2.36x	+9.51%	+2.96%	+5.96%	+55.56%	Strong Buy
Healthcare Plans	10	-0.12%	+1.21%	+5.01%	-15.66%	43.65x	2.07x	+12.19%	+3.78%	+9.23%	+14.08%	Buy
Health Information Services	54	-1.69%	-1.94%	-3.58%	-49.84%	42.11x	3.83x	+8.87%	+4.67%	+6.54%	+39.06%	Strong Buy
Medical Care Facilities	50	-1.25%	-1.53%	-4.54%	-42.75%	15.02x	5.23x	-80.60%	+7.33%	+16.04%	+20.06%	Buy
Medical Devices	139	+0.40%	-1.57%	-14.79%	-92.02%	23.79x	3.87x	+11.80%	+7.14%	+8.17%	+38.40%	Strong Buy
Medical Distribution	10	-0.79%	-0.70%	-3.80%	+44.38%	31.24x	3,562.64x	-56.46%	+3.41%	+21.83%	+9.05%	Buy
Medical Instruments & Supplies	57	-0.94%	-1.78%	+0.33%	-31.91%	222.67x	3.29x	+10.08%	+8.62%	+11.38%	+15.84%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock lose -23.93% over the past year, overperforming other healthcare stocks by 39 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -10.98% from Ironwood Pharmaceuticals's current stock price of $3.37.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #2 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 63.03% over the past year, overperforming other healthcare stocks by 126 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -0.27% from Pediatrix Medical Group's current stock price of $21.39.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: A.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 29, which is 3 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 75.56% over the past year, overperforming other healthcare stocks by 138 percentage points.

What are the healthcare stocks with highest dividends?

Out of 69 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.91%, which is 9 percentage points higher than the healthcare sector average of 1.92%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.48%, which is 8 percentage points higher than the healthcare sector average of 1.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.6%, which is 4 percentage points higher than the healthcare sector average of 1.92%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and down -1.76% over the last week. Corcept Therapeutics was the among the top losers in the healthcare sector, dropping -50.42% yesterday.

Corcept Therapeutics shares are trading lower after the company announced it received a Complete Response Letter for Relacorilant from the FDA.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -51.94% in the past year. It has overperformed other stocks in the healthcare sector by 11 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.75% in the past year. It has overperformed other stocks in the healthcare sector by 71 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -13.77% in the past year. It has overperformed other stocks in the healthcare sector by 49 percentage points.

Are healthcare stocks a good buy now?

57.52% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.56% over the next year.

7.72% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.81% of healthcare stocks are rated B (Buy), 47.84% are rated C (Hold), 24.68% are rated D (Sell), and 7.95% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 62.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.